Our data demonstrate that ANRIL promotes atherosclerosis in vivo and identify the ANRIL–miR-181b-5p–TMEM106B-NHE1–lysosomal pH axis as the underlying molecular pathogenic mechanism for the chromosome 9p21.3 genetic locus for coronary artery disease. This evidence concerns the gene SLC9A1 and atherosclerosis.